BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Jeremy ...
What was the structure and context of this transaction? This transaction involved the exercise of 100,000 stock options, immediately followed by the sale of the resulting shares in the open market.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Montai Therapeutics, a company harnessing AI to decode untapped, diverse chemistry to develop breakthrough medicines for chronic disease, today announced the ...
PRINCETON, N.J., Oct. 28, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using ...
SINGAPORE, Oct 27 (Reuters) - Targets for sustainable biofuels use and social aspects of the energy transition will be in focus at this year's United Nations climate summit, COP30, said Francesco La ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback